Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous...
                   
redorbit.com
May 22, 2008 10 related
        

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced preliminary results from two clinical trials conducted with investigational oral and intravenous formulations of RELISTOR(TM) (methylnaltrexone bromide). [read full story]                    

Add Comment
There are also 10 related articles
View all news articles about*:
Ambulatory America Canada Care Gastrointestinal Health Medical Medicines North Pain Patients Pharmaceuticals Progenics Remedies Research Symptoms Wyeth
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

Mothers Work fiscal 4Q loss narrows on cost cuts (AP)

yahoo.com
6 mins ago 2 related
        

Tuesday November 18, 7:32 am ET Mothers Work fiscal 4th-quarter loss narrows on reduced inventory, cost control efforts PHILADELPHIA (AP) -- Mothers Work Inc. said Tuesday that its fiscal fourth-quarter loss narrowed, helped by...

add comment
                   

Inmate Death Remains Mystery l WPRI.com

drugpolicycentral.com
7 mins ago
        

The 29-year-old West Warwick man was found dead in his cell in June at the Adult Correctional Institutions just a few days after his arrest on drug charges. (Tue Nov 18 04:33:11 2008 PST)[$drug_related(100%),...

add comment
                   

Check that check

djournal.com
8 mins ago
        

Some sites to check before sending or cashing a check BY DANZA JOHNSON Daily Journal TUPELO - When he looked in her mailbox recently, he saw a letter from what appeared to be Publisher's Clearing House, informing her she had...

add comment
                   

FDA Clears The DPL (Deep Penetrating Light) Therapy System For Over-the-Counter - Home Use

medicalnewstoday.com
9 mins ago 2 related
        

LED Technologies, LLC announced today that the U.S. Food and Drug Administration (FDA) cleared their DPL™ Therapy System for the relaxation of muscles and relief of muscle spasms, temporary relief of minor muscle and joint...

add comment